WHO-GMP Certified Commercial Pack · Product Code: AKP-025
Clobetasol Propionate 0.05% & Salicylic Acid 6.5% Ointment
Formulation Overview: Dual-action high-potency corticosteroid and keratolytic ointment formulated to desquamate thick hyperkeratotic plaques while enhancing dermal penetration to suppress underlying inflammation. Formulated with Clobetasol Propionate IP 0.05% w/w + Salicylic Acid IP 6.5% w/w (0.05% + 6.5% w/w) in Keratolytic Topical Ointment dosage form under Dermatology & Topicals, manufactured to IP / BP / USP Compendial standards and supplied in 15g / 30g Collapsible Aluminum Tube with Carton with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-025 |
|---|---|
| Therapeutic Sector | Dermatology & Topicals |
| Dosage Form | Keratolytic Topical Ointment |
| Active Ingredient | Clobetasol Propionate IP 0.05% w/w + Salicylic Acid IP 6.5% w/w |
| Strength / Purity | 0.05% + 6.5% w/w |
| Clinical Indication | Hyperkeratotic plaque psoriasis, chronic lichenified eczema, and scaling palmoplantar dermatoses |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 15g / 30g Collapsible Aluminum Tube with Carton |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C; keep tube tightly sealed |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |